Natco Pharma April-June Net Profit Falls 28% On Year to ₹4.81 Billion

Natco Pharma Ltd.’s April-June consolidated net profit dropped 28.1% YoY to ₹4.81 billion, while revenue slipped 2.5% to ₹13.29 billion. Sequentially, profit rose 18.2% and revenue gained 8.8%. Other income increased to ₹617 million from ₹481 million last year.

Total expenditure for the quarter grew to ₹8.19 billion from ₹6.07 billion a year ago, though finance costs fell to ₹32 million from ₹52 million. Tax outgo eased to ₹916 million from ₹1.35 billion.

The company announced an interim dividend of ₹2 per share, with August 19 as the record date.